GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
77.78
+0.93 (1.21%)
At close: Mar 13, 2026, 4:00 PM EDT
78.00
+0.22 (0.28%)
After-hours: Mar 13, 2026, 7:56 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.28 billion as of March 13, 2026. Its market cap has decreased by -18.13% in one year.
Market Cap
2.28B
Enterprise Value
2.22B
1-Year Change
-18.13%
Ranking
Category
Stock Price
$77.78
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.28B, a decrease of -87.27%. That is a compound annual growth rate of -31.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 2.25B | -40.13% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RadNet | 4.75B |
| Sotera Health Company | 3.96B |
| BillionToOne | 3.09B |
| Twist Bioscience | 2.87B |
| Veracyte | 2.58B |
| GRAIL | 1.87B |
| NeoGenomics | 1.11B |
| OPKO Health | 880.52M |